Canada markets closed

OPKO Health, Inc. (OPK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3200+0.0200 (+1.54%)
At close: 04:00PM EDT
1.3000 -0.02 (-1.52%)
After hours: 07:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.3000
Open1.3000
Bid1.3000 x 1800
Ask1.3300 x 1400
Day's Range1.2650 - 1.3600
52 Week Range0.8500 - 2.2400
Volume2,728,915
Avg. Volume8,382,022
Market Cap920.03M
Beta (5Y Monthly)1.81
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

    Conference call begins at 4:30 p.m. Eastern time todayMIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of BioReference Health. The transaction includes the sale of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health

  • GlobeNewswire

    OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

    MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participant

  • PR Newswire

    Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.